Clinical trials
Completed Gallbladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 4 |
| 2002 | 7 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 17 |
| Memorial Sloan Kettering Cancer Center | 6 |
| M.D. Anderson Cancer Center | 5 |
| Mayo Clinic | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| SWOG Cancer Research Network | 3 |
| University of Chicago | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Merck Sharp & Dohme LLC | 2 |
| NYU Langone Health | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 89 |
| Bile Duct Neoplasms | 57 |
| Pancreatic Neoplasms | 41 |
| Stomach Neoplasms | 37 |
| Carcinoma, Hepatocellular | 36 |
| Colonic Neoplasms | 33 |
| Rectal Neoplasms | 28 |
| Esophageal Neoplasms | 27 |
| Cholangiocarcinoma | 22 |
| Anus Neoplasms | 21 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.